CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $402,143
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$402,143. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-24 | Atlas Venture Fund VII L P 10% owner | Conversion | +1,315,859 | 4,885,804 | ||
| 2014-06-24 | Atlas Venture Fund VII L P 10% owner | Conversion | +746,926 | 5,632,730 | ||
| 2014-06-24 | Atlas Venture Fund VII L P 10% owner | Conversion · Series A Preferred Stock | −4,768,001 | 0 | ||
| 2014-06-24 | Atlas Venture Fund VII L P 10% owner | Conversion · Series B Preferred Stock | −17,651,253 | 0 | ||
| 2014-06-24 | Atlas Venture Fund VII L P 10% owner | Conversion · Series C Preferred Stock | −8,263,595 | 0 | ||
| 2014-06-24 | Atlas Venture Fund VII L P 10% owner | Conversion · Series D Preferred Stock | −4,690,696 | 0 | ||
| 2014-06-24 | THOMAS FRANK E Director | Grant or award · Stock Option (Right to Buy) | +13,327 | 13,327 | ||
| 2014-06-19 | Secor Alicia Chief Commercial Officer | Purchase | +4,000 | $20.00 | $80K | 4,000 |
Page 19 of 19 · 368 trades